Efficacy and safety of regorafenib in patients with metastatic and/or unresectable GI stromal tumor after failure of imatinib and sunitinib: a multicenter phase II trial (Q36910431)

From Wikidata
Jump to navigation Jump to search
scientific article published on 21 May 2012
edit
Language Label Description Also known as
English
Efficacy and safety of regorafenib in patients with metastatic and/or unresectable GI stromal tumor after failure of imatinib and sunitinib: a multicenter phase II trial
scientific article published on 21 May 2012

    Statements

    Efficacy and safety of regorafenib in patients with metastatic and/or unresectable GI stromal tumor after failure of imatinib and sunitinib: a multicenter phase II trial (English)
    Suzanne George
    Qian Wang
    Michael C Heinrich
    Christopher L Corless
    Meijun Zhu
    James E Butrynski
    Jeffrey A Morgan
    Andrew J Wagner
    Edwin Choy
    William D Tap
    Jeffrey T Yap
    Annick D Van den Abbeele
    Judith B Manola
    Sarah M Solomon
    Jonathan A Fletcher
    George D Demetri
    21 May 2012
    2401-2407

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit